We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+0.73%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$46.6B
AUM Growth
-$1.27B
(-2.6%)
Cap. Flow
-$2.28B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
19.53%
Holding
1,157
New
166
Increased
296
Reduced
323
Closed
125
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$208M |
| 2 |
Mastercard
MA
|
+$198M |
| 3 |
Kinder Morgan
KMI
|
+$174M |
| 4 |
Parker-Hannifin
PH
|
+$170M |
| 5 |
Check Point Software Technologies
CHKP
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$247M |
| 2 |
Pfizer
PFE
|
+$179M |
| 3 |
DuPont de Nemours
DD
|
+$149M |
| 4 |
Credicorp
BAP
|
+$138M |
| 5 |
McKesson
MCK
|
+$134M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.46% |
| 2 | Communication Services | 14.94% |
| 3 | Technology | 11.88% |
| 4 | Financials | 10.97% |
| 5 | Energy | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Mativ Holdings
MATV
$479M
| $22.6M | 0.05% |
547,895
+98,912
| +22% | +$4.22M |
|
227
PepsiCo
PEP
$196B
| $22.6M | 0.05% |
243,055
-89,914
| -27% | -$8.21M |
|
|
IFN
228
Aberdeen India Fund
IFN
$495M
| $22.4M | 0.05% |
827,096
-26,253
| -3% | -$687K |
|
229
Stagwell
STGW
$2B
| $22.1M | 0.05% |
1,150,471
+361,771
| +46% | +$7.62M |
|
230
Crown Holdings
CCK
$13B
| $21.9M | 0.05% |
490,865
-287,164
| -37% | -$13.8M |
|
231
PNC Financial Services
PNC
$99.1B
| $21.5M | 0.05% |
251,400
-9,603
| -4% | -$817K |
|
232
MetLife
MET
$62.4B
| $20.7M | 0.04% |
432,735
-15,243
| -3% | -$740K |
|
233
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
| – | – |
0
| – | – |
|
234
American International
AIG
$42.5B
| $20.4M | 0.04% |
376,780
-6,411
| -2% | -$350K |
|
235
Wheaton Precious Metals
WPM
$49.7B
| $20.2M | 0.04% |
1,013,624
+34,064
| +3% | +$848K |
|
236
Enerpac Tool Group
EPAC
$1.86B
| $19.9M | 0.04% |
653,519
-64,119
| -9% | -$2.12M |
|
|
JFC
237
DELISTED
JPMorgan China Region Fund, Inc.
JFC
| $19.9M | 0.04% |
1,309,804
-53,700
| -4% | -$853K |
|
238
Accenture
ACN
$106B
| $19.8M | 0.04% |
243,970
+128,420
| +111% | +$10.3M |
|
239
Hershey
HSY
$37.3B
| $19.6M | 0.04% |
205,852
-61,451
| -23% | -$5.69M |
|
240
iShares Core S&P Small-Cap ETF
IJR
$109B
| $19.5M | 0.04% |
373,562
+109,136
| +41% | +$5.94M |
|
|
BCR
241
DELISTED
CR Bard Inc.
BCR
| $19.2M | 0.04% |
134,453
+4,198
| +3% | +$620K |
|
242
Bank of America
BAC
$429B
| $19M | 0.04% |
1,115,125
-28,892
| -3% | -$460K |
|
243
Allstate
ALL
$70.6B
| $18.9M | 0.04% |
308,785
+9,620
| +3% | +$578K |
|
244
Procter & Gamble
PG
$340B
| $18.8M | 0.04% |
224,367
+3,735
| +2% | +$306K |
|
245
Steven Madden
SHOO
$3.17B
| $18.6M | 0.04% |
866,883
-36,416
| -4% | -$816K |
|
|
FEO
246
DELISTED
First Trust/abrdn Emerging Opportunity Fund
FEO
| $18.3M | 0.04% |
1,030,552
-56,644
| -5% | -$1.08M |
|
247
Biogen
BIIB
$30.9B
| $18.2M | 0.04% |
55,023
+16,233
| +42% | +$5.35M |
|
248
Carter's
CRI
$1.43B
| $17.7M | 0.04% |
228,872
+10,753
| +5% | +$831K |
|
249
Intuit
INTU
$91.1B
| $17.5M | 0.04% |
199,797
+68,803
| +53% | +$5.72M |
|
|
INFO
250
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $17.4M | 0.04% |
+743,697
| New | +$18.8M |
|
Similar funds
QCM
Lazard Asset Management's Q3 2014 Portfolio in Review
As of Q3 2014, Lazard Asset Management held 1,157 positions worth $46.6B, down 2.6% from $47.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Lazard Asset Management withdrew a net $2.28B in Q3 2014, closing 125 positions and reducing 323 holdings. Its most notable exit was TYCO INTL PLC COM SHS (IRL), an estimated $247M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Communication Services and Technology.
Against the trend, Lazard Asset Management opened a new position in Mastercard worth $193M.
- Lazard Asset Management's largest Q3 2014 buy was Mastercard: 2,605,801 shares worth $193M.
- Lazard Asset Management added most to Viatris in Q3 2014, an estimated $208M increase.
- Lazard Asset Management's biggest Q3 2014 reduction was Pfizer, cutting an estimated $179M.
- Lazard Asset Management fully exited TYCO INTL PLC COM SHS (IRL) in Q3 2014, selling an estimated $247M.
- Lazard Asset Management's ten largest holdings make up 20% of its $46.6B portfolio in Q3 2014.
- Lazard Asset Management opened 166 new positions and closed 125 in Q3 2014.
- Lazard Asset Management's portfolio value fell 2.6% quarter-over-quarter to $46.6B.
Based on Lazard Asset Management's 13F filing for Q3 2014, filed 7 Nov 2014.